Upgrade to SI Premium - Free Trial

Genmab A/S (GMAB)

25.10 +0.30 (1.21%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/26)

Latest Headlines

Form 6-K GENMAB A/S For: May 29 May 29, 2026 4:41 PM - SEC Filing Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons May 29, 2026 4:35 PM - StreetInsider Truist Securities Assumes Genmab A/S (GMAB) at Buy May 27, 2026 6:09 AM - StreetInsider Form SCHEDULE 13G/A GENMAB A/S Filed by: ORBIS INVESTMENT MANAGEMENT LTD May 15, 2026 1:05 PM - SEC Filing Form 6-K GENMAB A/S For: May 13 May 13, 2026 10:15 AM - SEC Filing Form 6-K GENMAB A/S For: May 12 May 12, 2026 1:54 PM - SEC Filing Capital Increase in Genmab as a Result of Employee Warrant Exercise May 12, 2026 1:47 PM - StreetInsider Genmab A/S (GEN:DC) (GMAB) PT Lowered to DKK2,250 at Deutsche Bank May 11, 2026 3:01 AM - StreetInsider Form 6-K GENMAB A/S For: May 08 May 8, 2026 4:18 PM - SEC Filing Major Shareholder Announcement May 8, 2026 3:05 PM - Globe NewsWire Genmab A/S (GMAB) PT Lowered to $33 at Morgan Stanley May 8, 2026 8:09 AM - StreetInsider DARZALEX royalties drive Genmab’s Q1 revenue higher amid expansion push May 7, 2026 2:38 PM - StreetInsider Form 6-K GENMAB A/S For: May 07 May 7, 2026 11:06 AM - SEC Filing Genmab A/S (GMAB) PT Lowered to $38 at H.C. Wainwright April 30, 2026 6:50 AM - StreetInsider Genmab gains as Goldman upgrades stock to Buy on increased pipeline confidence April 22, 2026 6:53 AM - StreetInsider Goldman Sachs Upgrades Genmab A/S (GEN:DC) (GMAB) to Buy April 22, 2026 12:56 AM - StreetInsider Goldman Sachs Upgrades Genmab A/S (GMAB) to Buy April 22, 2026 12:56 AM - StreetInsider Genmab A/S (GMAB) April 30, 35 and 40 calls active, share price down 2.5% April 21, 2026 3:12 PM - StreetInsider Form 6-K GENMAB A/S For: Apr 17 April 17, 2026 12:21 PM - SEC Filing Form 6-K GENMAB A/S For: Apr 17 April 17, 2026 11:24 AM - SEC Filing Genmab reduces share capital by DKK 1.9 million through cancellation April 17, 2026 10:58 AM - StreetInsider Genmab A/S Share Capital Reduction April 17, 2026 10:57 AM - StreetInsider Form 6-K GENMAB A/S For: Apr 14 April 14, 2026 12:02 PM - SEC Filing Major Shareholder Announcement April 14, 2026 10:44 AM - Globe NewsWire Form 6-K GENMAB A/S For: Apr 14 April 14, 2026 8:27 AM - SEC Filing Genmab reports $3.96 billion in DARZALEX sales for first quarter 2026 April 14, 2026 6:23 AM - StreetInsider Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2026 April 14, 2026 6:22 AM - Globe NewsWire Genmab shows safety data for ovarian cancer drug combination April 13, 2026 9:36 AM - StreetInsider Genmab Presents the Safety and Tolerability of Rinatabart Sesutecan (Rina-S®) in Combination with Bevacizumab in Advanced Ovarian Cancer April 13, 2026 9:35 AM - BizWire Form 6-K GENMAB A/S For: Apr 01 April 1, 2026 3:21 PM - SEC Filing Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons April 1, 2026 3:20 PM - StreetInsider Form 6-K GENMAB A/S For: Apr 01 April 1, 2026 2:44 PM - SEC Filing Major Shareholder Announcement April 1, 2026 3:24 AM - Globe NewsWire Form 6-K GENMAB A/S For: Mar 30 March 30, 2026 5:30 PM - SEC Filing Major Shareholder Announcement March 30, 2026 12:00 PM - Globe NewsWire Wolfe Research Starts Genmab A/S (GMAB) at Outperform March 26, 2026 4:08 PM - StreetInsider Form 6-K GENMAB A/S For: Mar 23 March 23, 2026 10:04 AM - SEC Filing Form 6-K GENMAB A/S For: Mar 19 March 19, 2026 2:34 PM - SEC Filing Genmab names new board leadership, grants employee equity awards March 19, 2026 2:22 PM - StreetInsider Constitution of the Board of Directors in Genmab A/S and Grant of Restricted Stock Units and Warrants to Employees in Genmab March 19, 2026 2:22 PM - StreetInsider Form 6-K GENMAB A/S For: Mar 19 March 19, 2026 10:29 AM - SEC Filing Form 6-K GENMAB A/S For: Mar 16 March 16, 2026 10:15 AM - SEC Filing Completion of Share Buy-back Program March 16, 2026 10:10 AM - StreetInsider Full Article List